Hillsdale Investment Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.49M Buy
139,900
+3,000
+2% +$53.4K 0.09% 258
2025
Q1
$2.44M Buy
+136,900
New +$2.44M 0.12% 197
2020
Q3
Sell
-10,300
Closed -$611K 630
2020
Q2
$611K Hold
10,300
0.06% 287
2020
Q1
$694K Hold
10,300
0.08% 214
2019
Q4
$868K Buy
+10,300
New +$868K 0.08% 227